Skip to main content
Fig. 7 | Cancer Nanotechnology

Fig. 7

From: g-C3N4-based photoresponsive magnetic nanocatalyst drives type-I photodynamic therapy under visible light irradiation, boosting chemo/chemodynamic synergistic therapy of colon cancer

Fig. 7

Disturbance of intracellular redox state in CCFCA-treated cells. A Monitoring intracellular ROS in cells treated for 48 h. Evaluation of B catalase activity and C intracellular GSH levels in CT26 cells treated with CDDP and nanocomposites for 48 h. (D) GSH depletion under the reduction of CCFCA

Back to article page